arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

ASP Isotopes Inc.

ASPI
$3.17 ▲ +0.01 (+0.32%) at close
Materials ·Miscellaneous Chemical Products ·USMiscellaneous Chemical Products
20 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

ASP Isotopes Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $389.0M
Dividend Yield
Revenue Growth 327.5%
Op. Margin None
ROIC -10.5%
FCF / Share $-0.22
Trailing P/E
Price / Book 1.6x
FCF Yield
Debt / Equity 0.23
info Valuation on last close. End-of-day price, Sep 22, 2026.

20-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.12M
↑ +327.5%
Net Income Profit after all expenses
$-33.99M
↓ -301.7%
Operating Margin Operating profit as % of sales
-150.2%
↑ +50.9% 0th
FCF / Share Free cash flow per share
$-0.22
↓ -13.2%
Long-Term Debt Long-term obligations
$59.77M
↑ +2.5%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
11
Financial Health
43
Cash Quality
32

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 5 years · 20 quarters